FGF2 and Duchenne muscular dystrophy: Indeed, it could be envisioned that mir214-3p targeting may have at least two beneficial effects on muscles of DMD patients, first decreasing fibrosis by inhibiting the differentiation of FAPs into myofibroblasts and second, promoting myogenesis by increasing the production of FGF-2.